Product Information
CARISOPRODOL 250 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3777 per EA under NDC 51525590101. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
51525590101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARISOPRODOLApproval Type
Authorized Generic (NDA)
FDA Application
NDA011792On Market Since
10/1/2016
Pharmacological Classes
Price Statistics
The NADAC for CARISOPRODOL 250 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 85.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3777 per EA |
|---|---|
| All-time high | $2.7381 (Mar 15, 2017) |
| All-time low | $0.3777 (Jun 17, 2026) |
| 52-week high | $0.5992 |
| 52-week low | $0.3777 |
| Median price | $1.3321 |
| Average price | $1.4800 |
| Largest weekly change | +80.1% (Aug 17, 2022) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARISOPRODOL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARISOPRODOL 250 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.3777 per EA (NDC 51525590101), effective Jun 24, 2026.
How has the price of CARISOPRODOL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARISOPRODOL 250 MG TABLET has declined 85.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARISOPRODOL 250 MG TABLET?
Since Nov 28, 2013, the NADAC for CARISOPRODOL 250 MG TABLET has ranged from a low of $0.3777 (Jun 17, 2026) to a high of $2.7381 (Mar 15, 2017), with a median of $1.3321 per EA.
Are there cheaper alternatives to CARISOPRODOL 250 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as CARISOPRODOL 250 MG TABLET, but none are currently priced below it.
Who manufactures CARISOPRODOL 250 MG TABLET?
CARISOPRODOL 250 MG TABLET (NDC 51525590101) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification